PortfoliosLab logo
Avanos Medical, Inc. (AVNS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US05350V1061

CUSIP

05350V106

IPO Date

Oct 21, 2014

Highlights

Market Cap

$584.99M

EPS (TTM)

-$8.27

Total Revenue (TTM)

$689.20M

Gross Profit (TTM)

$376.30M

EBITDA (TTM)

-$359.20M

Year Range

$11.84 - $25.36

Target Price

$14.00

Short %

3.47%

Short Ratio

2.24

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
AVNS vs. SPY
Popular comparisons:

Performance

Performance Chart


Loading data...

Returns By Period

Avanos Medical, Inc. (AVNS) returned -17.71% year-to-date (YTD) and -33.09% over the past 12 months. Over the past 10 years, AVNS returned -11.10% annually, underperforming the S&P 500 benchmark at 10.69%.


AVNS

YTD

-17.71%

1M

5.05%

6M

-36.68%

1Y

-33.09%

5Y*

-12.71%

10Y*

-11.10%

^GSPC (Benchmark)

YTD

-0.64%

1M

8.97%

6M

-2.62%

1Y

11.90%

5Y*

15.76%

10Y*

10.69%

*Annualized

Monthly Returns

The table below presents the monthly returns of AVNS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20258.17%-12.60%-4.78%-12.42%4.38%-17.71%
2024-14.44%-3.23%7.22%-9.19%10.12%0.05%20.08%1.25%-0.78%-22.26%2.57%-16.91%-29.02%
202313.23%-8.39%5.95%-0.67%-17.06%4.33%-4.26%-14.02%-3.90%-9.20%17.37%4.08%-17.11%
2022-12.72%16.95%-5.34%-12.96%-1.61%-4.71%3.77%-13.18%-11.57%1.70%21.44%0.59%-21.95%
2021-1.26%1.50%-4.87%-1.21%-7.20%-9.30%4.32%-13.02%-5.45%1.09%-4.34%14.92%-24.43%
2020-18.28%17.68%-16.91%15.30%-6.41%1.14%4.36%5.64%2.53%6.41%19.92%8.23%36.14%
20191.70%3.36%-9.35%-1.71%-10.18%15.74%-6.63%-18.52%12.90%17.57%-21.30%-2.77%-24.76%
20185.70%1.17%-6.68%2.80%15.90%4.28%-3.58%30.62%-4.99%-17.37%-15.71%-6.12%-3.01%
20174.03%1.53%-2.48%3.70%-9.01%9.29%2.39%12.61%-0.57%-6.40%15.16%-4.86%24.88%
2016-25.77%2.90%12.58%-1.98%10.40%4.60%6.37%5.38%-4.91%-6.66%14.84%-0.46%10.69%
2015-1.98%3.30%6.86%-1.46%-14.56%-2.22%0.59%-22.83%-9.54%4.36%7.78%4.44%-26.52%
2014-7.39%3.27%15.97%10.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AVNS is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AVNS is 1313
Overall Rank
The Sharpe Ratio Rank of AVNS is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of AVNS is 1010
Sortino Ratio Rank
The Omega Ratio Rank of AVNS is 99
Omega Ratio Rank
The Calmar Ratio Rank of AVNS is 2323
Calmar Ratio Rank
The Martin Ratio Rank of AVNS is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Avanos Medical, Inc. Sharpe ratios as of May 13, 2025 (values are recalculated daily):

  • 1-Year: -0.89
  • 5-Year: -0.33
  • 10-Year: -0.28
  • All Time: -0.26

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Avanos Medical, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Avanos Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Avanos Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Avanos Medical, Inc. was 83.44%, occurring on Apr 15, 2025. The portfolio has not yet recovered.

The current Avanos Medical, Inc. drawdown is 81.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.44%Sep 5, 20181662Apr 15, 2025
-53.8%Apr 9, 2015214Feb 11, 2016559May 2, 2018773
-12.63%Oct 22, 201414Nov 10, 201429Dec 22, 201443
-10.83%Jan 13, 201520Feb 10, 201527Mar 20, 201547
-9.56%Jun 19, 201829Jul 30, 20186Aug 7, 201835

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Avanos Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Avanos Medical, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -21.5%.


-0.100.000.100.200.300.400.500.6020212022202320242025
0.14
0.18
Actual
Estimate

Valuation

The Valuation section provides an overview of how Avanos Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AVNS relative to other companies in the Medical Devices industry. Currently, AVNS has a P/S ratio of 0.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AVNS in comparison with other companies in the Medical Devices industry. Currently, AVNS has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items